Glashutten, Germany

Eugen Uhlmann

This inventor holds 80 USPTO granted patents and 14 published patent applications, plus 14 CIPO patents and 17 EPO patents, primarily in Oligonucleotide Compounds (CPC class C12N2310-3231). Top assignees: Hoechst Aktiengesellschaft, Aventis Pharma Deutschland, Gmbh, Coley Pharmaceutical Gmbh. Active years: 1987-2020.

USPTO Granted Patents = 80 

% Patents Active = 73.8

 

 

Average Co-Inventor Count = 3.4

ph-index = 21

Forward Citations = 1,325(Granted Patents)

Forward Citations (Not Self Cited) = 1,227(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Konigstein, DE (1987)
  • Belmont, MA (US) (1989)
  • Konigstein/Taunus, DE (1995)
  • Glashuten, DE (1999)
  • Glashutten/Taunus, DE (1991 - 2000)
  • Glashütten/Taunus, DE (2001 - 2005)
  • Glashuetter, DE (2010)
  • Glashuetten, DE (2000 - 2019)
  • Glashutten, DE (1994 - 2020)
  • Glashütten, DE (2001 - 2020)

Company Filing History:

goldMedal32 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents
silverMedal11 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
bronzeMedal11 out of 27 
 
Coley Pharmaceutical Gmbh
 patents
4. 8 out of 41 
 
Coley Pharmaceutical Group, Inc.
 patents
5. 7 out of 1,855 
 
Sanofi-A Ventis Deutschland Gmbh
 patents
6. 6 out of 174 
 
Translate Bio, Inc.
 patents
7. 5 out of 6 
 
Isarna Therapeutics Gmbh
 patents
8. 3 out of 3 
 
Adiutide Pharmaceuticals Gmbh
 patents
9. 2 out of 4,486 
 
Pfizer Corporation
 patents
10. 2 out of 3,070 
 
The General Hospital Corporation
 patents
11. 1 out of 1 
 
Adiuttide Pharmaceuticals Gmbh
 patent
12. 1 out of 377 
 
Aventis Pharma S.a.
 patents
13. 1 out of 5,383 
 
Centre National De La Recherche Scientifique
 patents
14. 1 out of 9 
 
Hoechst Gmbh
 patents
15. 1 out of 1,853 
 
National Institute of Health and Medical Research
 patents
16. 1 out of 4 
 
Rana Therapeutics, Inc.
 patents
17. 1 out of 834,411 
Other
 patents
where one patent can have more than one assignee

Years Active: 1987-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Oligonucleotide Compounds
Immunostimulatory Activity
Modified TGF-Beta
Gene Expression Inhibition
CpG Oligonucleotides
Cleavable Linkers
Nucleic Acid Derivatives
Semi-Soft C-Class
Phosphate-Modified
Antisense Oligonucleotides
Multimeric Oligonucleotides
Synthetic Double-Stranded
80 patents (USPTO):Explore Patents

Title: The Innovative Journey of Eugen Uhlmann

Introduction:

Eugen Uhlmann, a pioneering inventor hailing from Glashuetten, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Eugen Uhlmann's latest patents include advancements in renewable energy technologies, smart home devices, and sustainable transportation solutions, showcasing his commitment to creating a more sustainable future.

Career Highlights:

Throughout his illustrious career, Eugen Uhlmann has been recognized for his innovative spirit and dedication to pushing the boundaries of technological advancement. His work has revolutionized industries such as telecommunications, robotics, and healthcare.

Collaborations:

Eugen Uhlmann has collaborated with leading research institutions, universities, and multinational corporations to bring his inventions to life. His ability to work across disciplines and industries has led to the development of cutting-edge technologies with far-reaching impacts.

Conclusion:

In conclusion, Eugen Uhlmann's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to push the limits of what is possible in the realm of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…